SCHEMBL19218532

SCHEMBL19218532

c1cc(-c2ccc(N(c3ccc4c(c3)-c3ccccc3C43c4ccccc4-c4ccccc43)c3ccc4c5ccccc5c5ccccc5c4c3)cc2)cc(-c2ccc3c(c2)oc2ccccc23)c1

nearest known ligand 0.34

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 2/20 0.34
PLA2G4A P47712 2/20 0.34
KDM4E B2RXH2 1/20 0.34
MEN1 O00255 1/20 0.34
ALDH1A1 P00352 1/20 0.34
MAPT P10636 1/20 0.34
HPGD P15428 1/20 0.34
KMT2A Q03164 1/20 0.34
MMP12 P39900 1/20 0.33
MMP13 P45452 1/20 0.33
AHR P35869 2/20 0.32
ALOX5 P09917 1/20 0.32
HCRTR1 O43613 1/20 0.31
NPC1 O15118 1/20 0.31
RAB9A P51151 1/20 0.31
ATM Q13315 1/20 0.31
PLA2G10 O15496 1/20 0.31
PRKDC P78527 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19218531 0.97 MEN1 (0.36) KDM4EMEN1ALDH1A1MAPTHPGD
SCHEMBL19218523 0.97 MEN1 (0.36) KDM4EMEN1ALDH1A1MAPTHPGD
SCHEMBL19218535 0.95 PLA2G2A (0.34) PLA2G2APLA2G4AKDM4EMEN1ALDH1A1
SCHEMBL19218519 0.95 KDM4E (0.35) PLA2G2APLA2G4AKDM4EMEN1ALDH1A1
SCHEMBL19218462 0.94 PLA2G2A (0.34) PLA2G2APLA2G4AKDM4EMEN1ALDH1A1
SCHEMBL19218536 0.92 PLA2G2A (0.33) PLA2G2APLA2G4AALOX5
SCHEMBL24904816 0.92 MMP12 (0.35) PLA2G2APLA2G4AKDM4EMEN1ALDH1A1
SCHEMBL19218522 0.91 KDM4E (0.36) PLA2G2APLA2G4AKDM4EMEN1ALDH1A1
SCHEMBL19218534 0.91 KDM4E (0.36) PLA2G2APLA2G4AKDM4EMEN1ALDH1A1
SCHEMBL19218530 0.91 ALOX5 (0.44) PLA2G2APLA2G4AALOX5PRKDC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10243148-B2 Aromatic amine compound, and organic electroluminescent elements including the compound IDEMITSU KOSAN CO., LTD. (JP) 2019-03-26 US disclosed
US-20170229649-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2017-08-10 US disclosed
US-20170229649-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2017-08-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10243148-B2 Aromatic amine compound, and organic electroluminescent elements including the compound H1-10, H1-0, H1-4 PLA2G2A 3413/4885PLA2G4A 3637/4885KDM4E 942/4885
US-20170229649-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE L1CAM, LEF1, PIEZO1 PLA2G2A 2128/4885PLA2G4A 2479/4885KDM4E 2978/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.